Blood Coagulation Factors
"Blood Coagulation Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, that are involved in the blood coagulation process.
| Descriptor ID |
D001779
|
| MeSH Number(s) |
D12.776.124.125 D23.119
|
| Concept/Terms |
Blood Coagulation Factors- Blood Coagulation Factors
- Blood Coagulation Factor
- Factor, Blood Coagulation
- Coagulation Factor, Blood
- Coagulation Factors, Blood
- Factors, Blood Coagulation
- Coagulation Factors
- Factor, Coagulation
- Factors, Coagulation
- Coagulation Factor
- Clotting Factors
- Factors, Clotting
|
Below are MeSH descriptors whose meaning is more general than "Blood Coagulation Factors".
Below are MeSH descriptors whose meaning is more specific than "Blood Coagulation Factors".
This graph shows the total number of publications written about "Blood Coagulation Factors" by people in this website by year, and whether "Blood Coagulation Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1996 | 2 | 1 | 3 |
| 1997 | 3 | 0 | 3 |
| 1998 | 2 | 1 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 3 | 0 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 1 | 2 |
| 2021 | 2 | 0 | 2 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Coagulation Factors" by people in Profiles.
-
Factor Eight Inhibitor Bypass Activity Use in Cardiac Surgery: A Propensity-matched Analysis of Safety Outcomes. Anesthesiology. 2024 Dec 01; 141(6):1051-1064.
-
Increasing optimal coagulation factor dosing in the paediatric emergency department: Update to a quality improvement study. Haemophilia. 2024 Mar; 30(2):367-374.
-
Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth. 2024 Feb; 38(2):388-393.
-
FEIBA Use in Neonatal Cardiac Surgery: A Risky Business That Needs Further Investigation. Anesth Analg. 2023 03 01; 136(3):470-472.
-
Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation. Sci Rep. 2021 11 08; 11(1):21852.
-
Indirect antiplatelet effects of rivaroxaban in a patient with intracranial hemorrhage: An underappreciated coagulopathy of factor Xa inhibitors? Am J Emerg Med. 2022 01; 51:426.e5-426.e7.
-
Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal. Am J Emerg Med. 2020 04; 38(4):806-809.
-
Does a dose relationship exist with prothrombin complex and factor Xa inhibitor reversal? An alternate perspective of Yohe et al. Am J Emerg Med. 2020 03; 38(3):686-687.
-
Use of factor concentrates for the management of perioperative bleeding: reply. J Thromb Haemost. 2018 10; 16(10):2113-2115.
-
Prothrombin Complex Concentrate Reversal of Coagulopathy in Emergency General Surgery Patients. World J Surg. 2018 08; 42(8):2383-2391.